Transcription of DICYNONE 500 OM Pharma - Modern Medicine
{{id}} {{{paragraph}}}
Contra-indicationsAcute to the active substance or to any of the asthma, proven hypersesnitivity to Special warnings and special precautions for useIf DICYNONE 500 is administered for a reduction of excessive and/or prolonged menstrual haemor-rhages, and no improvement is observed, possi-ble pathological causes should be looked for and Interactions with other medicinal products and other forms of interactionNo interaction is known up to Pregnancy and lactationPregnancy category C: For etamsylate, no clinical data on exposed pregnancies are studies do not indicate direct or indirect harmful effects with respect to pregnancy, embryo-nal/foetal development, parturition or postnatal development (see ).
DICYNONE 500 - p.2/2 Kinetics in particular situations It is not known if the pharmacokinetic properties of etamsylate are modified in patients suffering from
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}